Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication - FDA.org | The Health, Drug, Prescription, and GMP Supersite

FDA cGMP QSR GMP Training - popular online training courses by SkillsPlus International Inc.

Updated April 11, 2024

The original link broke.

You might also be interested in:

Dental Amalgam Fillings - FDA.gov

--- the original post follows below --

Read the full FDA Safety Communication:

Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication - FDA.org

According to the communication:

"The U.S. Food and Drug Administration (FDA) is providing recommendations about the use of dental amalgam in certain groups of people who may be at greater risk to the potential adverse health effects of mercury exposure, to include:

Pregnant women and their developing fetuses;
Women who are planning to become pregnant;
Nursing women and their newborns and infants;
Children, especially those younger than six years of age;
People with pre-existing neurological disease;
People with impaired kidney function; and
People with known heightened sensitivity (allergy) to mercury or other components of dental amalgam."

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

--------